Dr. Arpit Jain

DrNB (Medical Oncology), MD (Radiation Oncology), MBBS, ECMO

Consultant, Dept. of Medical Oncology

Book an Appointment

Rajiv Gandhi Cancer Institute, Sector - 5, Rohini, Delhi - 110 085

About

Dr. Arpit Jain is a dedicated and accomplished medical oncologist with a passion for advancing cancer care and research. Holding an esteemed DrNB Medical Oncology degree from the prestigious Rajiv Gandhi Cancer Institute and Research Centre in New Delhi.

His expertise encompasses the management of a wide spectrum of both hematological and non-hematological malignancies, including breast, lung, gastrointestinal, genitourinary and other solid tumors. Notably, he has successfully cleared the “European Certified Medical Oncologist” examination conducted by ESMO Medical Oncology. He holds membership in several esteemed organizations, including the European Society of Medical Oncology (ESMO), American Society of Clinical Oncology (ASCO), and ISMPO (International Society of Medical Oncology), among others.

His dedication to academic excellence is reflected in his numerous publications and research contributions, covering topics ranging from cancer treatment efficacy to molecular subtyping. His core ethos centers on the delivery of compassionate, patient-centric care, underpinned by his active involvement in cutting-edge clinical trials.

Specialized Areas

Comprehensive Chemotherapy for Various Cancers:

– Breast, Lung, and Prostate Cancers
– Other Solid Tumors including Gastrointestinal and Gynecological Cancers
– Hematological malignancies

Precision Targeted Therapies and Personalized Approach
Immunotherapy advancements
Cancer screening and prevention

Educational Background

European Certified Medical Oncologist (European Society of Medical Oncology)
DrNB in Medical Oncology (Rajiv Gandhi Cancer Institute and Research Centre, New Delhi) (National Board of Examination, New Delhi, India)
MD in Radiation Oncology (Mahatma Gandhi Memorial Medical College, Indore)
MBBS (Government Medical College, Bilaspur, C.G.)

Experience

Consultant (Medical Oncology) at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi since January 2023.
Attending Consultant (Medical Oncology) at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi from September 2022 to December 2022.
Senior Resident (Medical Oncology) at Rajiv Gandhi Cancer Institute and Research Centre, New Delhi from September 2019 to September 2022.
Senior Resident (Radiation Oncology) at MGM & MY Hospital & MGM Medical College, Indore from May 2016 to July 2019.
Junior Resident (Pediatrics) at Kalawati Saran Children’s Hospital, LHMC, New Delhi, March 2013-2014.
One-Year Compulsory Rotating Internship at CIMS, Bilaspur, C.G., during the academic year March 2013 to 2014.

Professional Journey

Achievements

Coordinated and engaged in various symposiums, webinars, and meetings.
Authored chapters on “Chemotherapy for Prostate Cancer” and “Recent Advances in Cancer Immunotherapy Management.”
Presented both oral and poster sessions in several national oncology conferences.
Participated as a speaker at various National Oncological Conferences.

Awards

Honored for exceptional research in lung cancer molecular diagnostics by NBE, 2022
Achieved the top academic performance during postgraduate study.
Attained distinctions in several subjects throughout the MBBS curriculum.

Research Contributions

Conducted thesis work during MD Radiation Oncology, focusing on a prospective study comparing treatment strategies for locally advanced squamous cell carcinoma of the head and neck.
Conducted research comparing the efficacy of liquid biopsy and tissue biopsy for detecting EGFR mutations in non-small cell lung carcinoma (NSCLC)

Publication

Jain A, Koyyala VP, Narayan S, Soni S, Redhu P, Jaju A. Hyper-Progressive Disease (HPD) during Immune Checkpoint Inhibitor (ICI) Therapy. Indian Journal of Medical and Paediatric Oncology. 2022 Apr 18;43(02):185-8.
Jain A, Joga S, Patel AB. The cost containment strategy by optimizing the bevacizumab dose for glioblastoma: Worthy or not?. Cancer Research, Statistics, and Treatment. 2021 Jul 1;4(3):579-80.
Goyal V, Jain A, Basu D, Soni S, Talwar V, Unveiling the uncommon: Disseminated intravascular coagulation as an unusual presentation of metastatic carcinoma prostate. IP Arch Cytol Histopathol Res 2023;8(2):119-122
Talwar V, Jain A. The genetic basis of breast cancer: A comprehensive overview. Curr Med Res Pract 2023
Bansal N, Goyal P, Basu D, Batra U, Sachdeva N, Joga S, Jain A, Doval DC. Impact of improving infection control and antibiotic stewardship practices on nosocomial infections and antimicrobial resistance in an oncology centre from India. Indian Journal of Medical Microbiology. 2023 Sep 1;45:100383.
Batra U, Nathany S, Sharma M, Jain P, Dhanda S, Singh H, Jain A, Mehta A. EGFR detection by liquid biopsy: Ripe for clinical usage. Future Oncology. 2021 Sep;18(1):85-92.
Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World Journal of Clinical Oncology. 2022 May 5;13(5):339.
Jain A , Jaju A , Iyer M , Arya R , Jain P , Metastases of malignant melanoma to stomach – An unusual presentation. Indian J Pathol Oncol 2020;7(3):480-482
Sharma M, Nathany S, Soni S, Jain A, Mehta A, Jain P, Batra U. Spectrum of BRAF mutations in Indian patients with NSCLC: A molecular kaleidoscope.
Joga S, Goyal S, Mehta A, Sharma M, Koyyala V, Doval D, Goyal P, Jain A, Aggarwal C, Patel AB, Nathani S, Suryavanshi M. P-21 Molecular subtypes (profile) of colorectal cancer and their correlation with clinical and pathological profile in a tertiary care centre in India. Annals of Oncology. 2022 Jun 1;33:S253-4.
Mathigatta Shivarudraiah, Shivashankara & Pathak, Jain A, Abhishek. (2022). How ctDNA Changing the Landscape of Management of Colorectal Cancers. Indian Cancer Awareness Journal.
Outcome and Complications of Microvascular Free Flap Head and Neck Reconstruction Analysis of 200 Cases (International Journal of Medical and Oral Research, January- June 2018)
Verma M, Jain A, Shivhare V, Katariya S, George A, Iyer M, Malviya A, Singh AP. A prospective study to compare the response and toxicity in patients treated with concomitant boost radiotherapy versus conventional radiotherapy in (LA-HNSCC). Journal of Evolution of Medical and Dental Sciences. 2019 Mar 25;8(12):868-72.
Katariya S, Verma M, Jain A, Shivhare V, George A, Iyer M, Malviya A, Singh AP. AN institutional study to evaluate the efficacy and toxicity of reirradiation using conventional radiotherapy for recurrent malignant disease. Journal of Evolution of Medical and Dental Sciences. 2019 Jan 21;8(3):174-7.
Soni S, Jain A, Goyal V, Narayan S, Redhu P , Talwar V. Modified FOLFIRINOX as the first-line chemotherapy in unresectable and metastatic pancreatic adenocarcinoma – a single-center experience in India” in Annals of Pancreatic Cancer. 2023